Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan
- 1 September 2015
- journal article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 14 (3) , 177-184.e4
Abstract
No abstract availableKeywords
Funding Information
- Department of Health (DOH-101-TD-B-111-001, DOH-102-TD-B-111-001)
- National Science Council (NSC-101-2314-B-002-141, NSC-102-2314-B-002-120, 100CAP1020-2)
This publication has 29 references indexed in Scilit:
- Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markersInternational Journal of Cancer, 2012
- Obesity-Driven Inflammation and Colorectal CancerCurrent Medicinal Chemistry, 2012
- Cytokines, Inflammation and Colon CancerCurrent Cancer Drug Targets, 2011
- Inflammation and Colon CancerGastroenterology, 2010
- Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary InterventionA Randomized Controlled TrialJAMA, 2002
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Protein Lipidation in Cell SignalingScience, 1995
- Regulation of the mevalonate pathwayNature, 1990